| Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies YC Sung, PR Jin, LA Chu, FF Hsu, MR Wang, CC Chang, SJ Chiou, ... Nature nanotechnology 14 (12), 1160-1169, 2019 | 310 | 2019 |
| Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer KW Huang, FF Hsu, JT Qiu, GJ Chern, YA Lee, CC Chang, YT Huang, ... Science advances 6 (3), eaax5032, 2020 | 197 | 2020 |
| CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer DY Gao, TT Lin, YC Sung, YC Liu, WH Chiang, CC Chang, JY Liu, ... Biomaterials 67, 194-203, 2015 | 133 | 2015 |
| Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development YC Sung, YC Liu, PH Chao, CC Chang, PR Jin, TT Lin, JA Lin, HT Cheng, ... Theranostics 8 (4), 894, 2018 | 86 | 2018 |
| Nanoparticle Delivery of MnO2 and Antiangiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma CC Chang, TK Dinh, YA Lee, FN Wang, YC Sung, PL Yu, SC Chiu, ... ACS Applied Materials & Interfaces 12 (40), 44407-44419, 2020 | 83 | 2020 |
| Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors Y Chen, YC Liu, YC Sung, RR Ramjiawan, TT Lin, CC Chang, KS Jeng, ... Scientific reports 7 (1), 44123, 2017 | 74 | 2017 |
| A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment JS Song, CC Chang, CH Wu, TK Dinh, JJ Jan, KW Huang, MC Chou, ... Proceedings of the National Academy of Sciences 118 (13), e2015433118, 2021 | 54 | 2021 |
| Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in mice CC Chang, Y Yang, DY Gao, HT Cheng, B Hoang, PH Chao, LH Chen, ... Journal of Drug Targeting 26 (5-6), 516-524, 2018 | 15 | 2018 |
| MCT Nanoemulsions for the Efficient Delivery of siRNA MS Padilla, M Tangsangasaksri, CC Chang, S Mecozzi Journal of Pharmaceutical Sciences 113 (3), 764-771, 2024 | | 2024 |
Yunching (Becky) Chen 陳韻晶Professor, Institute of Biomedical Engineering, National Tsing-Hua University在 email.unc.edu 的电子邮件经过验证
